Blood Cell Count-Based Inflammatory Markers Exhibit Superior Association with Diabetic Peripheral Neuropathy Compared to Protein-Based Markers.

与基于蛋白质的标志物相比,基于血细胞计数的炎症标志物与糖尿病周围神经病变表现出更强的相关性

阅读:7
作者:Ko Fu-Shun, Wu Tsung-Hui, Su Guan-Yu, Lin Yi-Hsiu, Juan Chi-Chang, Hwu Chii-Min
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a prevalent and disabling complication of type 2 diabetes mellitus, contributing to poor quality of life and increased healthcare burden. Chronic low-grade inflammation has been proposed as a key contributor to the pathogenesis of DPN. While various inflammatory markers have been studied, their diagnostic utility remains unclear, particularly when comparing protein-based markers and blood cell count-derived ratios. OBJECTIVE: This study aimed to investigate whether blood cell count-based inflammatory markers, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), are more strongly associated with DPN compared to protein-based markers, including interleukin-1 receptor antagonist (IL-1Ra) and high-sensitivity C-reactive protein (hsCRP). METHODS: In this cross-sectional study, 137 patients with type 2 diabetes were recruited. DPN was defined as a Michigan Neuropathy Screening Instrument (MNSI) score ≥2. All participants underwent physical examinations, questionnaire assessments, and laboratory evaluation of inflammatory markers. RESULTS: NLR was significantly elevated in the DPN group compared to controls (P < 0.05), while IL-1Ra and hsCRP levels showed no significant differences. Participants in the highest NLR tertile exhibited a higher DPN prevalence (19.0%) than those in the lowest tertile (8.8%). Multivariate linear regression identified NLR and HbA1(c) as independent predictors of MNSI scores. CONCLUSION: Our findings demonstrate that the NLR, an inflammation-related marker derived from peripheral blood cell counts, is significantly associated with DPN, whereas protein-based markers did not demonstrate clear associations. These findings suggest that NLR may serve as a simple, cost-effective biomarker for identifying patients at risk for DPN. Further longitudinal studies are warranted to clarify causal relationships and evaluate its prognostic value.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。